AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes

Adeno-associated virus (AAV) has become one of the most promising vectors in gene transfer in the last 10 years with successful translation to clinical trials in humans and even market approval for a first gene therapy product in Europe. Administration to humans, however, revealed that adaptive immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Daniel J, Edmonson, Shyrie C, Podsakoff, Gregory M, Pien, Gary C, Ivanciu, Lacramioara, Camire, Rodney M, Ertl, Hildegund, Mingozzi, Federico, High, Katherine A, Basner-Tschakarjan, Etiena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588448/
https://www.ncbi.nlm.nih.gov/pubmed/26445723
http://dx.doi.org/10.1038/mtm.2015.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588448/
https://www.ncbi.nlm.nih.gov/pubmed/26445723
http://dx.doi.org/10.1038/mtm.2015.29

Ejemplares similares